Disorders of Vitamin B12 Metabolism
Solomon LR • Blood Rev
Key Finding
Early detection prevents irreversible neurological damage
Original title: “Disorders of cobalamin (vitamin B12) metabolism: emerging concepts in pathophysiology, diagnosis and treatment”
Plain English Summary
Comprehensive review of B12 metabolism disorders, diagnostic approaches, and emerging treatment concepts.
In-Depth Analysis
Background
Dr. Lawrence R. Solomon published this review in Blood Reviews (PMID: 16814909), covering disorders of cobalamin (B12) metabolism with emerging concepts in pathophysiology, diagnosis, and treatment.
Study Design
Comprehensive review synthesizing advances in understanding B12 absorption, transport, cellular metabolism, and clinical manifestations of deficiency.
Key Findings
B12 metabolic pathway:
- •Dietary B12 binds intrinsic factor (IF) in stomach
- •IF-B12 complex absorbed in terminal ileum
- •Transcobalamin II transports B12 to tissues
- •Intracellular conversion to methylcobalamin and adenosylcobalamin
Causes of deficiency by mechanism:
| Mechanism | Examples |
|---|---|
| Inadequate intake | Vegan diet, malnutrition |
| Malabsorption | Pernicious anemia, gastric surgery, Crohn's |
| Transport defects | Transcobalamin deficiency (rare) |
| Cellular defects | Inborn errors of metabolism |
| Drug-induced | Metformin, PPIs, H2 blockers |
Mechanistic Insights
B12 functions as coenzyme for:
- •Methionine synthase: Homocysteine → methionine (methylation)
- •Methylmalonyl-CoA mutase: Propionate metabolism (myelin synthesis)
Deficiency causes both methylation defects (neuropsychiatric) and propionate accumulation (neurological).
Clinical Implications
Functional markers (MMA, homocysteine) detect deficiency earlier than serum B12 alone. Neurological damage can occur with "low-normal" B12 levels.
Metabolic Health Perspective
Understanding B12 metabolism explains why supplementation works differently by route. High-dose oral B12 (1000-2000 mcg) can overcome absorption defects through mass action.
Paradigm Relevance
How this study applies to different clinical perspectives:
Standard Medical
RelevantConventional clinical guidelines used by most doctors
Research Consensus
RelevantCurrent scientific understanding, often ahead of guidelines
Metabolic Optimization
RelevantProactive targets for optimal health, not just disease absence
Study Details
- Type
- Review Article
Topic
Related Biomarkers
Calculate & Evaluate on Metabolicum
Original Source
Related Studies
Proton Pump Inhibitors, H2-Receptor Antagonists, Metformin, and Vitamin B-12 Deficiency: Clinical Implications
Miller JW • Advances in Nutrition • 2018
PPIs/H2RAs: HR 1.83 (95% CI 1.36-2.46) for B12 deficiency with ≥10 months use; Metformin: mean B12 reduction of -54 pmol/L (95% CI -81 to -26)
Clinical Guidelines for B12 Deficiency Recognition and Management
Langan RC, Goodbred AJ • Am Fam Physician • 2017
Neurological protection requires B12 levels above 500 pg/mL
Comprehensive Review of Vitamin B12 Deficiency
Stabler SP • N Engl J Med • 2013
MMA testing identifies tissue-level deficiency missed by serum B12